Adagio Medical (ADGM) Stock Price, News & Analysis

Company Overview

Adagio Medical, Inc. is a medical device company focused on developing catheter-based technologies for the treatment of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. The company’s products are designed for use in cardiac ablation procedures, which create precisely positioned lesions in heart tissue to interrupt abnormal electrical signals.

Adagio Medical’s primary technology is the Integrated Cardiac Ablation System, or iCLAS. The system uses ultra-low-temperature cryoablation and a flexible catheter platform intended to create continuous, transmural lesions around targeted areas of the heart. The company has developed its technology to support the treatment of complex arrhythmias, including persistent and long-standing persistent atrial fibrillation.

Adagio Medical has conducted clinical development activities in the United States and internationally. Its technologies have been the subject of clinical studies and regulatory filings, although the availability and approved uses of specific products may vary by jurisdiction. The company is headquartered in California and focuses primarily on advancing its proprietary ablation systems toward regulatory authorization and broader clinical use.

Key Stats

• Today's Range: $0.12 to $0.13
• 50-Day Range: $0.13 to $0.80
• 52-Week Range: $0.12 to $2.58
• Volume: 1.48 million shs
• Average Volume: 3.28 million shs
• Market Capitalization: $2.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Hold

Adagio Medical Stock Analysis - MarketRank™

Adagio Medical scored higher than 42% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Hold

Consensus Rating

Adagio Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Adagio Medical has a consensus price target of $3.50, representing about 2,592.3% upside from its current price of $0.13.

Amount of Analyst Coverage

Adagio Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Adagio Medical are expected to decrease in the coming year, from ($1.25) to ($1.75) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Adagio Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Adagio Medical is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Adagio Medical has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.02% of the float of Adagio Medical has been sold short.

Short Interest Ratio / Days to Cover

Adagio Medical has a short interest ratio ("days to cover") of 2.26, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Adagio Medical has recently increased by 59.27%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Adagio Medical does not currently pay a dividend.

Dividend Growth

Adagio Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

Search Interest

2 people have searched for ADGM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

2 people have added Adagio Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Adagio Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.81% of the stock of Adagio Medical is held by insiders.

Percentage Held by Institutions

48.08% of the stock of Adagio Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 10/09/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:ADGM
• Previous Symbol: NASDAQ:ADGM
• CIK: 2006986
• Web: adagiomedical.com
• Phone: (949) 348-1188
• Fax: N/A
• Employees: 41
• Year Founded: 2023

Price Target and Rating

• Average Price Target for Adagio Medical: $3.50
• High Price Target: $4.00
• Low Price Target: $3.00
• Potential Upside/Downside: +2,592.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.08 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -661.85%
• Return on Assets: -73.35%

Debt

• Debt-to-Equity Ratio: 4.00
• Current Ratio: 1.41
• Quick Ratio: 1.15

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.59 per share
• Price / Book: 0.22

Miscellaneous

• Outstanding Shares: 22,210,000
• Free Float: 20,475,000
• Market Cap: $2.89 million
• Optionable: N/A
• Beta: 0.01